Preoperative MRI following ultrasound detection of breast cancer can find more cancers.
Preoperative MR imaging can help detect additional sites of cancer in women whose breast cancer was detected at screening ultrasound, according to a study published in the journal Radiology.
Korean researchers performed a retrospective review to determine additional cancer yield of MR imaging in women who had breast cancer that had been detected through screening ultrasonography and to identify a subgroup of women who are likely to benefit from preoperative MR imaging.
A total of 374 women with a median age of 48 years were included in the study. All had breast cancer detected at screening ultrasound; 321 of the women had invasive breast cancer. Following MR imaging, 21 of the 374 (5.6 percent) were diagnosed with additional cancer (positive predictive value of biopsy, 42.0 percent) and index invasive lobular cancer (ILC) histologic type was significantly associated with additional cancer detected at MR imaging. Two factors associated with detection of additional cancers by MRI among women with index invasive cancer were premenopausal status and lobular histologic type.
The researchers concluded that preoperative MR imaging helped to detect additional sites of cancer among some women with breast cancer detected at screening US. “Women with index ILC and premenopausal women are more likely to benefit from preoperative MR imaging,” they wrote.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.